錦欣生殖(01951.HK)逆市續升6.5%再創紀錄高
錦欣生殖(01951.HK)逆市突破上周五盤中所創紀錄高位13.78元,最高見13.98元,現造13.8元,續升6.5%,成交增至1,620萬股,涉資2.2億元。
花旗上周五表示,錦欣生殖於中國業務利潤率可能上升,因為對保護隱私單人間和VIP服務的求持續增長。同時,預計這家輔助生殖服務提供商的美國患者數量將回升。此外,最近有關候選新冠疫苗樂觀消息可能有利於錦欣生殖業務表現,促進潛在併購,維持其「買入」評級及看16元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.